These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
882 related items for PubMed ID: 18064932
1. [Hirsutism]. van Zuuren EJ, Pijl H. Ned Tijdschr Geneeskd; 2007 Oct 20; 151(42):2313-8. PubMed ID: 18064932 [Abstract] [Full Text] [Related]
2. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study. Karakurt F, Sahin I, Güler S, Demirbas B, Culha C, Serter R, Aral Y, Bavbek N. Adv Ther; 2008 Apr 20; 25(4):321-8. PubMed ID: 18389188 [Abstract] [Full Text] [Related]
6. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1. Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E, American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE), Androgen Excess and PCOS Society (AES). Endocr Pract; 2015 Nov 20; 21(11):1291-300. PubMed ID: 26509855 [Abstract] [Full Text] [Related]
7. Effects of an oral contraceptive containing cyproterone acetate (Diane-35) on the symptoms, hormone profile, and ovarian volume of hirsute women with polycystic ovarian syndrome. Prelević GM, Puzigaća Z, Balint-Perić LA. Ann N Y Acad Sci; 1993 May 28; 687():255-62. PubMed ID: 8323181 [No Abstract] [Full Text] [Related]
10. Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism. De Leo V, Fulghesu AM, la Marca A, Morgante G, Pasqui L, Talluri B, Torricelli M, Caruso A. Gynecol Endocrinol; 2000 Dec 28; 14(6):411-6. PubMed ID: 11228061 [Abstract] [Full Text] [Related]
11. Hirsutism - from diagnosis to use of antiandrogens. Unluhizarci K, Karaca Z, Kelestimur F. Front Horm Res; 2013 Dec 28; 40():103-14. PubMed ID: 24002408 [Abstract] [Full Text] [Related]
12. Gonadotropin-releasing hormone agonist (GnRH-A) in hirsutism. Falsetti L, Pasinetti E, Ceruti D. Acta Eur Fertil; 1994 Dec 28; 25(5):303-6. PubMed ID: 7660719 [Abstract] [Full Text] [Related]
13. The clinical evaluation of hirsutism. Somani N, Harrison S, Bergfeld WF. Dermatol Ther; 2008 Dec 28; 21(5):376-91. PubMed ID: 18844715 [Abstract] [Full Text] [Related]
14. Treatment of hirsutism and acne in hyperandrogenism. Moghetti P, Toscano V. Best Pract Res Clin Endocrinol Metab; 2006 Jun 28; 20(2):221-34. PubMed ID: 16772153 [Abstract] [Full Text] [Related]
15. Comparison of sequential cyproterone acetate/estrogen versus spironolactone/oral contraceptive in the treatment of hirsutism. O'Brien RC, Cooper ME, Murray RM, Seeman E, Thomas AK, Jerums G. J Clin Endocrinol Metab; 1991 May 28; 72(5):1008-13. PubMed ID: 1827125 [Abstract] [Full Text] [Related]
19. Cyproterone acetate or drospirenone containing combined oral contraceptives plus spironolactone or cyproterone acetate for hirsutism: randomized comparison of three regimens. Kelekci KH, Kelekci S, Yengel I, Gul S, Yilmaz B. J Dermatolog Treat; 2012 Jun 28; 23(3):177-83. PubMed ID: 21254871 [Abstract] [Full Text] [Related]